Cargando…

Immune checkpoint inhibitor induced lichenoid reactions: A systematic review of characteristics and treatment outcomes

Detalles Bibliográficos
Autores principales:	Abduelmula, Abrahim, Awan, Ramsha, Saif, Hammad, Howard, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867185/ https://www.ncbi.nlm.nih.gov/pubmed/35243402 http://dx.doi.org/10.1016/j.jdin.2021.12.003

Ejemplares similares

Immune checkpoint inhibitor lichenoid eruption due to pembrolizumab
por: McCormick, Benjamin Joseph, et al.
Publicado: (2023)

Treatment outcomes in patients with papuloerythroderma of Ofuji: A systematic review
por: Mufti, Asfandyar, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Induced Psoriasiform, Spongiotic, and Lichenoid Dermatitis: A Novel Clinicopathological Pattern
por: Kost, Yana, et al.
Publicado: (2022)

PERFORATING LICHENOID REACTION TO AMLODIPINE
por: Lakshmi, Chembolli, et al.
Publicado: (2008)

Oral lichenoid reaction to tobacco
por: Panta, Prashanth, et al.
Publicado: (2016)

Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based Review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

Photosensitive lichenoid skin reaction to capecitabine
por: Shah, Rena A., et al.
Publicado: (2017)

Lichenoid Reaction Caused by Antihistamines and Corticosteroids
por: Suryana, Ketut
Publicado: (2020)

Isoniazid-induced lichenoid eruption reaction
por: Kedar, Aishwarya Kishor, et al.
Publicado: (2023)

Biologic treatment outcomes in refractory bullous pemphigoid: An evidence-based review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

Lichenoid drug eruption associated with Bendamustine
por: Kusano, Y, et al.
Publicado: (2016)

Expression of survivin and p53 in oral lichen planus, lichenoid reaction and lichenoid dysplasia: An immunohistochemical study
por: Basheer, Shaini, et al.
Publicado: (2017)

Characteristics of Immune Checkpoint Inhibitors Trials Associated With Inclusion of Patients With HIV: A Systematic Review and Meta-analysis
por: Sorotsky, Hadas, et al.
Publicado: (2019)

Dermoscopy of “Lichenoid Pseudovesicular Papular Eruption on Nose”
por: Bains, Anupama, et al.
Publicado: (2021)

Lichenoid Drug Reaction Post-COVID Vaccination with the Modified Chimpanzee Adenovirus
por: García-Mendoza, Paola, et al.
Publicado: (2022)

Estimation of silver nucleolar organizer regions in oral lichen planus, oral lichenoid reactions and oral lichenoid dysplasia
por: Chandrakala, J, et al.
Publicado: (2017)

Oral Lichenoid Reaction: An Uncommon Side Effect of Rituximab
por: Giudice, Amerigo, et al.
Publicado: (2019)

Lichenoid Keratosis Simulating Melanoma: a Case Report
por: Barrutia, Leire, et al.
Publicado: (2022)

Endocrine Toxicity and Outcomes in Patients With Metastatic Malignancies Treated With Immune Checkpoint Inhibitors
por: Al Ashi, Suleiman I, et al.
Publicado: (2021)

Immune checkpoint inhibitors: friend or foe for osteoporosis
por: Tang, Jun
Publicado: (2023)

Lichenoid contact reaction to eugenol presenting as oral lichen planus
por: Behzad, Melika, et al.
Publicado: (2014)

Hawley retainer and lichenoid reaction: a rare case report
por: Elhadad, Mahmoud Ahmed, et al.
Publicado: (2019)

Motorcycling can be dangerous: verrucous lichenoid reaction to a tattoo()()
por: Rosan, Isadora, et al.
Publicado: (2021)

Dermoscopy of Pigmented Purpuric Lichenoid Dermatitis of Gougerot and Blum in an HIV-infected Patient
por: Garrido, Pedro Miguel, et al.
Publicado: (2020)

Drugs Associated With the Development of Palmoplantar Keratoderma: A Systematic Review
por: Mirali, Sara, et al.
Publicado: (2021)

Porokeratosis Presenting with a Benign Lichenoid Keratosis-Like Appearance
por: Kim, Min Seok, et al.
Publicado: (2015)

The Use of Janus Kinase Inhibitors for Lichen Planus: An Evidence-Based Review
por: Abduelmula, Abrahim, et al.
Publicado: (2023)

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2019)

Clinical Characteristics and Outcomes in Immune Checkpoint Inhibitor Therapy-Associated Myocarditis
por: Thakker, Ravi A., et al.
Publicado: (2021)

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus
por: Liu, Jia, et al.
Publicado: (2022)

Blood pressure surveillance in cancer patients treated with immune checkpoint inhibitors
por: Tan, Sean, et al.
Publicado: (2023)

Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature
por: Mufti, Asfandyar, et al.
Publicado: (2021)

Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
por: Abushukair, Hassan Mohammed, et al.
Publicado: (2022)

Lichenoid Drug Eruption after Low-Dose Imatinib Mesylate Treatment
por: Lee, Jae-Hyung, et al.
Publicado: (2013)

Prominent Alopetic Lesions of Lichenoid Drug Eruption Treated with Topical Tacrolimus
por: Cho, Hong Ki, et al.
Publicado: (2014)

Keratosis lichenoides chronica: A case report and focused overview of the literature
por: Aromolo, Italo Francesco, et al.
Publicado: (2021)

Lichenoid drug eruption induced by pravastatin; it is possible to prescribe other statins?()
por: Navarro-Triviño, Francisco J., et al.
Publicado: (2023)

Generalized Lichenoid Skin Lesions: A Rare Manifestation of Secondary Syphilis
por: Singh, Satyendra K., et al.
Publicado: (2023)

The natural history of oral mucosal lesions with both lichenoid and epithelial dysplastic features: a systematic review
por: Raj, A. Thirumal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_du2isu03cb19uardk54n8n9amo